Under way, not recruiting
The Effect of Deep Versus Moderate Muscle Relaxants in Men During and After Robotic Surgery for Prostate Cancer
NCT03808077 · Memorial Sloan Kettering Cancer Center · Updated 9 March 2026
- What is being tested
- Rocuronium 0.3mg/kg/hr; Rocuronium 1.5mg/kg/hr
- For
- Prostate Cancer
- Kind of study
- Tests a treatment or device on volunteers. Phase 2.
- Who can join
- Ages 18 years to 80 years. About 139 people. The full rules are on the registry page.
- Where
- United States
- When
- Starts or started 14 Jan 2019, ends Jan 2027. Registered 17 Jan 2019.
- Results
- Posted on the registry on 19 June 2025.
In the researchers' words
The purpose of this study is to determine if there is a difference in intra-abdominal pressure which surgeons use during surgery and post-surgery pain in men who undergo robotic prostate surgery with deep neuromuscular blockade (NMB), compared with moderate NMB.
Sites
- Memorial Sloan Kettering Cancer CenterNew York, New York, United States